Study Provides Scaffold to Selectively Target Drug Breakdown Process
St. Jude Children's Research HospitalScientists at St. Jude Childrenâs Research Hospital explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.